BACKGROUND & AIMS
Growth hormone and insulin-like growth factor I (IGF-I) stimulate small bowel growth. The aim of this study was to analyze whether IGF-I mediates enterotrophic actions of growth hormone.
METHODS
IGF-I transgenic mice that overexpress an IGF-I transgene driven by the mouse metallothionein I promoter and are growth hormone deficient were compared with wild-type littermates. Growth of small bowel, abundance and localization of messenger RNAs for the IGF-I transgene, and insulin-like growth factor-binding protein 3 were assayed.
RESULTS
Small bowel length and mass were greater in IGF-I transgenic mice than in wild-type mice. Villus height, crypt depth, and crypt cell mitoses were greater in jejunum of transgenics than wild-type mice, but jejunal disacharidase activities were not increased. The transgene was expressed strongly in villus epithelial cells. Insulin-like growth factor-binding protein 3 messenger RNA was localized in the lamina propria. Regional expression of both correlated with the increase in mucosal mass.
CONCLUSIONS
Effects of IGF-I overexpression on intestinal length and mucosal mass were similar to effects of growth hormone overexpression observed previously. Excess of IGF-I increased crypt cell proliferation, whereas excess of growth hormone did not increase crypt cell proliferation. IGF-I excess stimulated differentiation of intestinal epithelial cells less effectively than growth hormone excess.
[1]
D. Le Roith,et al.
Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors.
,
1997
.
[2]
Brown Al,et al.
Insulin-like growth factor binding proteins: gene structure and expression.
,
1992
.
[3]
F. V. Schaik,et al.
Sequence of cDNA encoding human insulin-like growth factor I precursor
,
1983,
Nature.
[4]
K. Copeland,et al.
Induction of immunoreactive somatomedin C human serum by growth hormone: dose-response relationships and effect on chromatographic profiles.
,
1980,
The Journal of clinical endocrinology and metabolism.